Navigation Links
Neuro Intervention Market: New Strategic Landscape & Market Forecast
Date:3/7/2013

DUBLIN, March 7, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Neuro Intervention Market: New Strategic Landscape & Market Forecast" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The global neuro intervention market resumed double digit growth and is poised to surpass $1.2 billion in revenue by the end of the year.

The rollout of the much anticipated Target Tenzing family of rapid detachment embolic coils from Stryker, coupled with stellar performance from both the flow diverter and neurovascular thrombectomy devices segments contributed to overall growth.

Neurovascular Intervention Market is still undergoing consolidation with leading players acquiring innovative startups at an unprecedented rate. After Covidien's acquisition of ev3 for $2.6 billion, the company snapped Reverse Medical's line of neurovascular guide catheters.

Stryker, which became the undisputed market leader after its acquisition of Boston Scientific's neurovascular division for $1.5 billion, coughed another $130 million for Concentric Medical and announced its intentions to acquire a next generation Flow Diverter.

After acquiring Micrus Endovascular for $480 million, Codman & Shurtleff spun off its surgical instruments business to Symmetry Medical for $165m in cash in a move that would sharpen its focus on the neuro intervention space and replenish its financial war chest for targeted acquisitions.

Neuro Intervention Market Report is the latest update of Medtech Ventures best-selling strategic audit of the industry. The report analyzes revenue and growth trends for the entire sector with special emphasis on embolic coils, intracranial stents, Flow Diverters, liquid embolics and thrombectomy devices.

The report also segments the market based on disease areas with special emphasis on endovascular cerebral aneurysm repair (ECAR) and both acute and chronic cerebral ischemia.

Neuro Intervention Market Report examines Leading companies technologies, product offerings, market shares and strategic positions, uncovers areas with maturing trends as well as areas with high growth potential and provides an updated forecast to 2017.


Companies Mentioned

- Balt Extrusion
- Cardiatis
- CoAxia
- Codman Neurovascular
- Concentric Medical
- Covidien
- ev3
- Gore Medical
- ITGI Medical
- Johnson & Johnson
- Merlin MD
- MicroVention
- Micrus Endovascular
- MindFrame
- NeuroInterventions
- NeuroVasx
- Nfocus Neuromedical
- Penumbra
- Phenox GmbH
- Reverse Medical
- Sequent Medical
- Stryker
- Surpass Medical
- Terumo
- Valor Medical



For more information visit http://www.researchandmarkets.com/research/tw3x7d/neuro


Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +1-353-1-481-1716
Sector: Central Nervous System



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
4. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
5. Neurocrine Biosciences Reports First Quarter 2012 Results
6. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
7. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
8. San Diego Based Neurosurgeon Offers Groundbreaking Treatment to Restore Function for People Suffering from Mobility Inhibiting Paralysis
9. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
10. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
11. Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market Will Reach USD 33.3 Billion Globally in 2017: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of ... collection of specialty vendors and unique items from across the nation, this holiday-themed event ... wellness services offered by the VNA. The boutique will be open Saturday, November ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):